Issue Archive
July 2017 | Volume 16 | Issue 7
Original Articles
Update on the Systemic Risks of Superpotent Topical Steroids
INTRODUCTION: The potential for systemic effects due to percutaneous absorption of superpotent topical steroids has been a longstanding concern. The Food and Drug Administration currently recommends l...
Read MoreDrivers of Healthcare Costs Among the Costliest Patients With Psoriasis Over Three Years in a United States Health Plan
OBJECTIVE: To compare patients with psoriasis by cost level over 3 years. METHODS: Psoriasis patients in a large US health plan in 2011-2013 were identified. Four groups were created by healthcare ...
Read MoreExpert Consensus on Absorbable Advanced Suspension Technology for Facial Tissue Repositioning and Volume Enhancement
BACKGROUND: Signs of facial aging include wrinkles, loss of subcutaneous volume, decreased tone, texture, and sagging of the skin. The objective of this review is to determine whether facial suspensio...
Read MoreA 1% Colloidal Oatmeal Cream Alone is Effective in Reducing Symptoms of Mild to Moderate Atopic Dermatitis: Results from Two Clinical Studies
BACKGROUND: The epidermal barrier in patients with atopic dermatitis (AD) is deficient in ceramides and cathelicidins. Such epidermal defects may be a trigger for AD, thereby encouraging research towa...
Read MoreThe Role of a Natural Mollusk Egg-Derived Ingredient in Facial Appearance
New cosmeceutical ingredients that improve skin appearance are of interest to the dermatologist. Cryptomphalus aspersa is a snail raised on farms in Spain for its mucinous secretions and eggs. These n...
Read MoreOrf Virus Infection in Humans: A Review With a Focus on Advances in Diagnosis and Treatment
Ecthyma contagiosum, also called contagious pustular dermatosis, is a zoonotic disease caused by the orf virus (OrfV). As a member of the poxviridae family and parapoxvirus genus, this dermatotropic v...
Read MoreHair Loss Myths
INTRODUCTION: Hair loss is a common complaint seen in dermatology clinics. From frustration and attempts at self-help, patients with hair loss may present to the dermatologist with false beliefs, or m...
Read More
Case Reports
Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis
Psoriasis is a chronic inflammatory cutaneous disease that affects 2-3% of the general population. Up to 30% of patients with psoriasis also develop psoriatic arthritis, a chronic inflammatory and pro...
Read MoreTreatment of Annular Elastolytic Giant Cell Granuloma With Topical Tretinoin
Annular elastolytic giant cell granuloma, also known as actinic granuloma, is a rare skin condition with a chronic course that is often resistant to treatment. Literature is sparse, and only a handful...
Read MoreAcquired Epidermodysplasia Verruciformis and Its Relationship to Immunosuppressive Therapy: Report of a Case and Review of the Literature
Introduction: Epidermodysplasia verruciformis (EV) is a rare inherited dermatosis characterized by increased susceptibility to human papilloma virus infection. Acquired EV occurs in patients with comp...
Read MoreLow-dose Methotrexate for Vitiligo
BACKGROUND: Treatment of vitiligo is aimed at repigmentation and often consists of multiple modalities, none of which are universally or rapidly successful. Extensive cases are most often treated with...
Read MoreRandomized, Split-Face/Décolleté Comparative Trial of Procedure Enhancement System for Fractional non-Ablative Laser Resurfacing Treatment
INTRODUCTION: A topical proprietary procedural enhancement system (PES) containing a combination of active ingredients including a tripeptide and hexapeptide (TriHex Technologyâ„¢, Alastin Procedu...
Read MorePostoperative Pyoderma Gangrenosum Following Video-Assisted Thoracic Surgery
Pyoderma gangrenosum (PG) is a neutrophilic, ulcerative dermatosis that can develop at sites of cutaneous trauma, including surgical incisions, a phenomenon known as pathergy. The characteristic lesio...
Read MoreLichenoid Dermatitis From Interferon alpha-2a in a Patient With Metastatic Renal Cell Carcinoma and Seronegative HCV
Cutaneous reactions to interferon, including a lichenoid drug reaction, are most commonly reported in patients undergoing treatment for hepatitis C virus (HCV) infection. There have been case reports ...
Read More
